CV Lattes
ORCID
Abstract
Prostate cancer's ability to progress to a non-responsive phase to androgen deprivation therapy emphasizes the importance of study on adjuvant treatments. Recent research suggests estrogen receptors as possible therapeutic targets in neoplasias and they can be modulated by drugs such as Raloxifene. In this context, this study aims to evaluate the histoprotective and anti-inflammatory pote…